naturopathic doctor news & review
About NDNR
Razi Ann Berry and David Tallman, DC, ND, founded NDNR in 2005. For two decades, NDNR has documented, published, and disseminated case-based evidence for naturopathic and integrative practitioners worldwide, advancing clinical knowledge through practitioner-led case reports and peer-reviewed education.
Our archive holds the largest collection of applied natural medicine case reports in existence, documenting real interventions, dosages, and patient outcomes. NDNR publishes The Journal of Applied Natural Medicine, produces live and virtual summits, masterclasses, and multimedia clinical education, and is a NANCEAC-accredited continuing education provider.
NDNR serves NDs, MDs, DOs, DCs, NPs, PAs, PhDs, and allied healthcare professionals.
Razi Ann Berry has received the AANP Champion of Naturopathic Medicine Award, the Mindshare Rising Tide Award, the Mindshare Best Digital Media Award, and Corporation of the Year.
NDNR has been recognized by SCNM, CNDA, OANP, and NYANP, the Foundations Project and Mindshare. Since 2014, NDNR has hosted the annual Physician Choice Awards.
NDNR 20 Years of Publishing
Key milestones from 2005 to today
Custom Publishing
Increased Intracellular NAD+ Levels via Oral Supplementation With a Novel Liposomal Delivery Method: A Non-Randomized Crossover Study
Blair E, Miller A, McDonald R. Introduction: NAD+ is a critical coenzyme for cellular energy production, DNA repair, and sirtuin activity, with levels known to decline with age. While oral NAD+ supplementation is proposed for healthy aging benefits, its efficacy in...
IS TYLENOL SAFE DURING PREGNANCY?
Understanding Risk Factors, Not Causation Learn how much Tylenol pregnant women can safely take, what risk factors matter, and why glutathione status—not acetaminophen itself—determines safety during pregnancy. IN THIS ARTICLE • Key Takeaways: Tylenol Safety...
Quantum Energy Field and Its Effects on Cellular ATP Production Rates in Human Cells
Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Quantum Upgrade based on Leela Quantum technology, influences adenosine triphosphate (ATP) production in human cell lines. This double-blind...
Featured News
Allergy Research News Release
RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...
Strive Compounding Pharmacy Files Federal Antitrust Lawsuit Against Eli Lilly and Novo Nordisk
ARCADIA TALLMAN Strive Compounding Pharmacy has filed a federal antitrust lawsuit against Eli Lilly and Novo Nordisk, alleging a coordinated effort to suppress competition and restrict patient access to lawful compounded GLP-1 medications. The complaint, filed on...
Quantum Fields and Frequency Medicine
RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow within integrative and...
Increased Intracellular NAD+ Levels via Oral Supplementation With a Novel Liposomal Delivery Method: A Non-Randomized Crossover Study
Blair E, Miller A, McDonald R. Introduction: NAD+ is a critical coenzyme for cellular energy production, DNA repair, and sirtuin activity, with levels known to decline with age. While oral NAD+ supplementation is proposed for healthy aging benefits, its efficacy in...
Epstein–Barr Virus (EBV) as a Contributor to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Dr. Todd Maderis, ND Exploring immune dysregulation, viral reactivation, mitochondrial impairment, and treatment implications in post-EBV fatigue syndromes. Abstract This article examines the role of Epstein–Barr virus (EBV) reactivation and immune exhaustion in the...
Intravenous Phosphatidylcholine in Severe Refractory Mast Cell Activation Syndrome: A Case Report
Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral intolerance through membrane lipid therapy. This case report describes a 34-year-old woman with severe, treatment-refractory mast cell activation...